NCT01597895 Estimate the Effect of Telaprevir and Boceprevir on Maraviroc Pharmacokinetics in Healthy Subjects Status COMPLETED Phase PHASE1
NCT01597258 Safety And Efficacy Of Crizotinib (Regulatory Post Marketing Commitment Plan) Status COMPLETED Phase N/A
NCT01597193 Safety Study of Enzalutamide (MDV3100) in Patients With Incurable Breast Cancer Status COMPLETED Phase PHASE1
NCT01595867 Abuse Potential Assessment of Intranasally Administered EMBEDA Compared To Morphine Sulfate Controlled Release And Placebo Status COMPLETED Phase PHASE1
NCT01595438 Ceftazidime-Avibactam Compared With Doripenem Followed by Oral Therapy for Hospitalized Adults With Complicated UTIs (Urinary Tract Infections) Status COMPLETED Phase PHASE3
NCT01592240 Monthly And Twice Monthly Subcutaneous Dosing Of PF-04950615 (RN316) In Hypercholesterolemic Subjects On A Statin Status COMPLETED Phase PHASE2
NCT01591421 P13Kinase Inhibitor BKM120 in Combination With Panitumumab in Metastatic/Advanced RAS-Wild Type Colorectal Cancer. Status COMPLETED Phase PHASE1/PHASE2
NCT01589614 A Study To Investigate The Effect Of Erythromycin On The Pharmacokinetics Of PH-797804 Status COMPLETED Phase PHASE1
NCT01586442 Comparison of Eplerenone Versus Spironolactone in Heart Failure Patients With Glucose Intolerance or Type 2 Diabetes Status COMPLETED Phase PHASE3
NCT01582698 TBE Seropersistence up to 10 Years After First Booster in Adults Status COMPLETED Phase PHASE4
NCT01582048 Multicenter Study of Peritransplantation Immunosuppression for Mismatched Hematopoietic Cell Transplantation After Reduced Intensity Conditioning Status TERMINATED Phase PHASE2
NCT01580813 Evaluating the Effects of a Study Medication on Exercise Function in Type 2 Diabetes Status COMPLETED Phase NA
NCT01579903 Relative Bioavailability Of Two Formulations Of Moroctocog Alfa (AF-CC) Status COMPLETED Phase PHASE1
NCT01578850 Study Conducted in Subjects With Rheumatoid Arthritis Who Have Moderate to Severe Disease Activity Despite Methotrexate Therapy With or Without Other Non Biologic Disease Modifying Antirheumatic Drugs (DMARDs)for at Least 12 Weeks Prior to Screening Status COMPLETED Phase PHASE4
NCT01577589 A 2-part Study to Assess Local Tolerability, Safety and Pharmacokinetics of Ceftaroline in Healthy Subjects Status COMPLETED Phase PHASE1
NCT01577381 Efficacy, Safety And Tolerability Study Of RN6G In Subjects With Geographic Atrophy Secondary to Age-related Macular Degeneration Status TERMINATED Phase PHASE2
NCT01576406 Hepatic Impairment Study For Crizotinib In Advanced Cancer Patients Status COMPLETED Phase PHASE1